Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multinational Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the ReVision Optics, Inc. PresbyLens Corneal Inlay for the Improvement of Near Vision in Presbyopic Subjects With MRSE From -0.50 to +1.00

NCT01373580 is registered in ClinicalTrials.gov with ReVision Optics, Inc. as lead sponsor.

NCT NCT01373580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01373580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multinational Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the ReVision Optics, Inc. PresbyLens Corneal Inlay for the Improvement of Near Vision in Presbyopic Subjects With MRSE From -0.50 to +1.00
Lead sponsor
ReVision Optics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2010
Completion date
December 31, 2016
Enrollment
373 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

presbyopia